Research use only. All compounds are for laboratory research. Not for human or veterinary use. 21+.

Tesofensine: What the Research Shows

Tesofensine (also designated NS-2330) is a small-molecule research compound, not a peptide, belonging to the phenyltropane chemical class. It is studied in preclinical research as a monoamine-reuptake inhibitor, characterized in in-vitro and animal models for its interaction with the serotonin, norepinephrine, and dopamine transporters.

Because it is a small organic molecule rather than an amino-acid chain, Tesofensine has no peptide sequence; it is identified by its molecular formula, SMILES string, CAS number, and PubChem CID. As supplied for research, it is a powder that is soluble in suitable solvents on reconstitution.

Verified data

Verified compound data

Property Value
Compound name Tesofensine (NS-2330)
Compound class Small molecule (phenyltropane); NOT a peptide
CAS number 195875-84-4
PubChem CID 11370864
Molecular formula (free base) C17H23Cl2NO
Molecular weight (free base) ~328.3 g/mol
SMILES CN1[C@@H]2C[C@H](C3=CC(Cl)=C(Cl)C=C3)[C@@H](COCC)[C@H]1CC2
Amino acid sequence None: small molecule, not a peptide
Physical form Powder

Data verified against PubChem (CID 11370864, free base C17H23Cl2NO, MW ~328.3) and Cayman Chemical / Wikipedia (CAS 195875-84-4). Note: the two chlorine atoms are part of the dichlorophenyl ring of the molecule; C17H23Cl2NO is the free base, not a dihydrochloride salt. Salt forms (e.g., citrate, tartrate) are separately registered and carry different molecular weights; confirm the supplied form against the batch COA.

Mechanism

Research-context mechanism

In preclinical literature, Tesofensine is studied as an inhibitor of the reuptake of three monoamine neurotransmitters (serotonin, norepinephrine, and dopamine) at their respective transporters in in-vitro and animal models. Research characterizes this transporter-interaction profile at the cellular and neuropharmacological level. These interactions are described strictly within research models; they are not established human-use mechanisms and describe no human outcome.

Research summary

Current research summary

Tesofensine appears in a neuropharmacology research literature focused on monoamine-transporter pharmacology. Reported research areas include:

  • Serotonin / norepinephrine / dopamine reuptake-inhibition assays (in vitro)
  • Monoamine-transporter binding and selectivity studies
  • Central-nervous-system signaling research models (animal level)
  • Phenyltropane structure-activity studies

The existing body of work spans in-vitro and animal models. There are no completed large controlled human clinical trials establishing the compound for any approved therapeutic use, and it is not an FDA-approved drug. All framing here is strictly laboratory research.

Questions

Frequently Asked Questions

What is Tesofensine?

Tesofensine (NS-2330) is a small-molecule research compound, not a peptide, studied in preclinical research as a monoamine-reuptake inhibitor acting at the serotonin, norepinephrine, and dopamine transporters. It is supplied as a powder and is not approved for human use.

Is Tesofensine a peptide?

No. Tesofensine is a small organic molecule of the phenyltropane class. It has no amino-acid sequence and is identified by its molecular formula (free base C17H23Cl2NO), SMILES, CAS number (195875-84-4), and PubChem CID 11370864.

What is the molecular formula and weight of Tesofensine?

The free base of Tesofensine is C17H23Cl2NO with a molecular weight of approximately 328.3 g/mol (PubChem CID 11370864). The two chlorine atoms are part of the dichlorophenyl ring, not a salt counter-ion. Salt forms carry different weights. Confirm the supplied form against the batch COA.

What is the CAS number for Tesofensine?

The CAS registry number for Tesofensine (free base) is 195875-84-4.

How is Tesofensine stored in a research setting?

Tesofensine is stored as a powder at 2 to 8°C, protected from light and humidity. Reconstituted material is held at 4°C and used within about 30 days, avoiding repeated freeze-thaw cycles.

Is Tesofensine approved for human use?

No. Tesofensine is not an FDA-approved drug and is not intended for human consumption. It is offered strictly as a research compound for laboratory use.

For research use only. Not for human or veterinary use. Not approved by the FDA. 21+

All compounds described in Vantage Aminos research content are sold for laboratory and scientific research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition. For research use only.
  • HPLC + MS tested, every batch
  • U.S. synthesized
  • Batch COA on the product page